To the Editor: Dr Iwashyna and colleagues demonstrated high rates of new-onset cognitive and functional impairments among elderly survivors of severe sepsis.1 Converging evidence from human and preclinical studies suggests such consequences of sepsis may be associated with the effects of the immune system on the brain.
Proinflammatory cytokines (ie, interleukins and tumor necrosis factor) released as result of inflammation can reach the brain in a number of ways: via peripheral afferents (ie, the vagus nerve), entry through leaky circumventricular areas in the blood-brain barrier, or active transport.2 Once in the brain, the cytokine signal stimulates microglia to secrete inflammatory mediators (ie, cytokines, chemokines, and proteases) from its monocytes and macrophages.3 These local inflammatory mediators can affect neuronal function and synaptic plasticity by increasing oxidative stress and weakening astrocytic tight junctions.3 They also increase metabolism and reuptake of neurotransmitters (ie, serotonin, noradrenalin, and dopamine) and stimulate the hypothalamic-pituitary-adrenal axis.2 We believe this may explain the occurrence of a range of cognitive and affective problems observed in sepsis survivors. In healthy volunteers, immune activation has been shown to increase circulating cytokines, induce anxiety and low mood, and decrease cognitive performance.4
Both normal aging and neurodegenerative disease have been shown to prime the microglia to produce an exaggerated inflammatory response during activation of the peripheral innate immune system.5 Central acetylcholine, which seems to exert inhibitory control over microglia, can be reduced in elderly patients if they use drugs with anticholinergic properties or have (incipient) dementia.3 Elderly patients are prone to develop delirium, even after apparently innocuous infection.3 In an experimental mouse model of neurodegenerative disease, transient systemic inflammation was associated with acute exacerbation of cognitive and motor impairments and rapid disease progression.5 Taken together, these findings may advance understanding of short- and long-term cognitive and functional impairments observed among patients of sepsis and why elderly patients can be particularly vulnerable.
Research has now focused on possible pathways to control microglial activation, by (1) direct inhibition by minocycline, a tetracyclic anti-inflammatory agent; (2) peripheral blockade of cytokines by, eg, anti–tumor necrosis factor; or (3) augmentation of inhibitory cholinergic control by cholinesterase inhibitors.3 Minocycline has been shown to attenuate both microglial activation and behavioral changes following administration of an immune activating agent in mice.3 More research in this area is required.
Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported.
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.